Evidence map›Paper›PMID 40670506›Full record

ArticleScientific reports2025

Application of UiO-66 MOF for rifampicin removal and post-adsorption antimicrobial activity against MRSA.

S A Abdel Moaty, Amna A Kotp, Asmaa M Salah, Ahmed A Farghali, Zienab E Eldin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S A Abdel MoatyChemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt. dr.samahchemy2010@yahoo.com.
Amna A KotpMaterials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Beni-Suef, 62511, Egypt.
Asmaa M SalahChemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt.
Ahmed A FarghaliMaterials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Beni-Suef, 62511, Egypt.
Zienab E EldinMaterials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Beni-Suef, 62511, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Water is essential to all living forms, shaping both our planet and the human body. But their great toxicity makes dangerous contaminants like new chemicals, antibiotics, heavy metals, and microbes major dangers to water systems. This article looks at the creation and use of UiO-66, a zirconium-based metal-organic framework (MOF), as a dual-function material for rifampicin adsorption and antibacterial action. Using solvothermal techniques, UiO-66 MOFs were created and characterized by X-ray diffraction (XRD), nitrogen adsorption-desorption, field-emission scanning electron microscopy (FESEM), thermogravimetric analysis (TG), Fourier-transform infrared spectroscopy (FTIR), and Brunauer-Emmett-Teller (BET) analysis. Batch testing maximized factors like pH, starting concentration, adsorbent amount, and contact time to improve rifampicin removal effectiveness. The findings showed a maximum adsorption capacity (q

Indexed as

Metal-Organic FrameworksMethicillin-Resistant Staphylococcus aureusRifampinWater PurificationAdsorptionAnti-Bacterial AgentsCell LineEnvironmental Restoration and RemediationHumansKlebsiella pneumoniaeMetal NanoparticlesWater PollutionZirconiumAnti-Bacterial AgentsMetal-Organic FrameworksRifampinZirconiumAntibacterial activityBiocompatibilityDrug delivery.MRSARifampicin adsorptionUiO-66

Identifiers

PMID40670506
PMCPMC12267463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.